Call Options

9 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $173 - $194
3 New
3 $0
Q1 2021

Apr 12, 2021

SELL
$59.34 - $66.74 $22,549 - $25,361
-380 Closed
0 $0
Q4 2020

Jan 19, 2021

BUY
$57.74 - $65.43 $21,941 - $24,863
380 New
380 $23,000
Q2 2020

Jul 10, 2020

SELL
$54.82 - $64.09 $164 - $192
-3 Closed
0 $0
Q4 2019

Jan 10, 2020

BUY
$49.21 - $64.19 $147 - $192
3 New
3 $0
Q2 2019

Jul 24, 2019

SELL
$44.62 - $49.34 $2,007 - $2,220
-45 Closed
0 $0
Q1 2019

Apr 17, 2019

BUY
$45.12 - $53.8 $1,759 - $2,098
39 Added 650.0%
45 $2,000
Q3 2018

Oct 29, 2018

BUY
$55.19 - $62.25 $275 - $311
5 Added 500.0%
6 $0
Q2 2018

Jul 18, 2018

BUY
$50.53 - $62.98 $50 - $62
1 New
1 $0

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.